China rights to Isotechnika's transplant drug sold to 3SBio for US$6 million - Winnipeg Free Press Print
Winnipeg Free Press"3SBio's commercial expertise and leading franchise in nephrology in China make the company an ideal partner for the region and provides further validation ...Isotechnika Pharma signs $6m commercialization agreement for transplant organ

... read more